231 related articles for article (PubMed ID: 29083055)
1. Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.
Tokarz D; Martins JS; Petit ET; Lin CP; Demay MB; Liu ES
J Bone Miner Res; 2018 Mar; 33(3):499-509. PubMed ID: 29083055
[TBL] [Abstract][Full Text] [Related]
2. Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH.
Yuan Y; Jagga S; Martins JS; Rana R; Pajevic PD; Liu ES
PLoS One; 2021; 16(5):e0252348. PubMed ID: 34043707
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
Liu ES; Martins JS; Raimann A; Chae BT; Brooks DJ; Jorgetti V; Bouxsein ML; Demay MB
J Bone Miner Res; 2016 May; 31(5):929-39. PubMed ID: 26751835
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
5. FGF23 Neutralizing Antibody Partially Improves Bone Mineralization Defect of HMWFGF2 Isoforms in Transgenic Female Mice.
Xiao L; Homer-Bouthiette C; Hurley MM
J Bone Miner Res; 2018 Jul; 33(7):1347-1361. PubMed ID: 29502359
[TBL] [Abstract][Full Text] [Related]
6. Effects of Active Vitamin D or FGF23 Antibody on
Lira Dos Santos EJ; Chavez MB; Tan MH; Mohamed FF; Kolli TN; Foster BL; Liu ES
J Dent Res; 2021 Dec; 100(13):1482-1491. PubMed ID: 33906518
[TBL] [Abstract][Full Text] [Related]
7. Comparison of calcimimetic R568 and calcitriol in mineral homeostasis in the Hyp mouse, a murine homolog of X-linked hypophosphatemia.
Leifheit-Nestler M; Kucka J; Yoshizawa E; Behets G; D'Haese P; Bergen C; Meier M; Fischer DC; Haffner D
Bone; 2017 Oct; 103():224-232. PubMed ID: 28728941
[TBL] [Abstract][Full Text] [Related]
8. Dentoalveolar Defects in the
Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL
J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267
[TBL] [Abstract][Full Text] [Related]
9. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
[TBL] [Abstract][Full Text] [Related]
10. YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling.
Kegelman CD; Coulombe JC; Jordan KM; Horan DJ; Qin L; Robling AG; Ferguson VL; Bellido TM; Boerckel JD
J Bone Miner Res; 2020 Jan; 35(1):196-210. PubMed ID: 31610061
[TBL] [Abstract][Full Text] [Related]
11. Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice.
Aono Y; Hasegawa H; Yamazaki Y; Shimada T; Fujita T; Yamashita T; Fukumoto S
J Bone Miner Res; 2011 Apr; 26(4):803-10. PubMed ID: 20939065
[TBL] [Abstract][Full Text] [Related]
12. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance.
Tang SY; Herber RP; Ho SP; Alliston T
J Bone Miner Res; 2012 Sep; 27(9):1936-50. PubMed ID: 22549931
[TBL] [Abstract][Full Text] [Related]
14. Crossfibrillar mineral tessellation in normal and Hyp mouse bone as revealed by 3D FIB-SEM microscopy.
Buss DJ; Reznikov N; McKee MD
J Struct Biol; 2020 Nov; 212(2):107603. PubMed ID: 32805412
[TBL] [Abstract][Full Text] [Related]
15. Conductive Hearing Loss in the Hyp Mouse Model of X-Linked Hypophosphatemia Is Accompanied by Hypomineralization of the Auditory Ossicles.
Delsmann MM; Seist R; Stürznickel J; Schmidt FN; Mansour A; Kobelski MM; Broocks G; Peichl J; Oheim R; Praetorius M; Schinke T; Amling M; Demay MB; Stankovic KM; Rolvien T
J Bone Miner Res; 2021 Dec; 36(12):2317-2328. PubMed ID: 34523743
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption.
Johnson K; Levine K; Sergi J; Chamoun J; Roach R; Vekich J; Favis M; Horn M; Cao X; Miller B; Snyder W; Aivazian D; Reagan W; Berryman E; Colangelo J; Markiewicz V; Bagi CM; Brown TP; Coyle A; Mohammadi M; Magram J
J Bone Miner Res; 2017 Oct; 32(10):2062-2073. PubMed ID: 28600887
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis.
Fowler TW; Acevedo C; Mazur CM; Hall-Glenn F; Fields AJ; Bale HA; Ritchie RO; Lotz JC; Vail TP; Alliston T
Sci Rep; 2017 Mar; 7():44618. PubMed ID: 28327602
[TBL] [Abstract][Full Text] [Related]
18. Perilacunar bone tissue exhibits sub-micrometer modulus gradation which depends on the recency of osteocyte bone formation in both young adult and early-old-age female C57Bl/6 mice.
Rux CJ; Vahidi G; Darabi A; Cox LM; Heveran CM
Bone; 2022 Apr; 157():116327. PubMed ID: 35026452
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.
Aono Y; Yamazaki Y; Yasutake J; Kawata T; Hasegawa H; Urakawa I; Fujita T; Wada M; Yamashita T; Fukumoto S; Shimada T
J Bone Miner Res; 2009 Nov; 24(11):1879-88. PubMed ID: 19419316
[TBL] [Abstract][Full Text] [Related]
20. Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia.
Rana R; Baker JT; Sorsby M; Jagga S; Venkat S; Almardini S; Liu ES
JCI Insight; 2023 Sep; 8(17):. PubMed ID: 37490334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
